Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among analysts that have covered the stock in the last year is $137.50.

ADUS has been the topic of several recent analyst reports. JMP Securities reaffirmed a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Wednesday, July 16th. UBS Group started coverage on Addus HomeCare in a research note on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 price target on the stock. Barclays boosted their price objective on Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 19th. Royal Bank Of Canada boosted their price objective on Addus HomeCare from $133.00 to $134.00 and gave the stock an “outperform” rating in a research note on Friday, August 22nd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, October 8th.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $121.46 on Tuesday. The business’s 50 day moving average is $114.98 and its 200-day moving average is $111.61. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $2.24 billion, a PE ratio of 26.81, a PEG ratio of 1.86 and a beta of 0.86. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.45 by $0.04. The business had revenue of $349.44 million for the quarter, compared to analyst estimates of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare’s quarterly revenue was up 21.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.35 EPS. Sell-side analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of the business’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the transaction, the executive vice president owned 56,980 shares of the company’s stock, valued at approximately $6,656,403.60. The trade was a 11.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the transaction, the director directly owned 5,067 shares in the company, valued at approximately $582,350.31. This represents a 23.67% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,310 shares of company stock valued at $3,958,375. 4.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently made changes to their positions in ADUS. Oppenheimer & Co. Inc. raised its position in shares of Addus HomeCare by 71.2% during the first quarter. Oppenheimer & Co. Inc. now owns 10,340 shares of the company’s stock worth $1,023,000 after acquiring an additional 4,302 shares during the last quarter. WCM Investment Management LLC raised its position in shares of Addus HomeCare by 4.9% during the first quarter. WCM Investment Management LLC now owns 494,791 shares of the company’s stock worth $48,143,000 after acquiring an additional 23,176 shares during the last quarter. Principal Financial Group Inc. raised its position in shares of Addus HomeCare by 18.3% during the first quarter. Principal Financial Group Inc. now owns 475,818 shares of the company’s stock worth $47,054,000 after acquiring an additional 73,720 shares during the last quarter. Huntleigh Advisors Inc. raised its position in shares of Addus HomeCare by 15.8% during the first quarter. Huntleigh Advisors Inc. now owns 3,758 shares of the company’s stock worth $372,000 after acquiring an additional 512 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Addus HomeCare by 40.4% during the first quarter. Bank of New York Mellon Corp now owns 164,118 shares of the company’s stock worth $16,230,000 after acquiring an additional 47,222 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.